US Patent Issued to Helsinn Healthcare, Anacardio on June 9 for "Piperidine urea derivatives for use as inotropic agents" (Italian, Swedish, Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,941, issued on June 9, was assigned to Helsinn Healthcare SA (Lugano/Pazzallo, Switzerland) and Anacardio AB (Solna, Sweden). "Piperidine ur... Read More

US Patent Issued to LUMOSA THERAPEUTICS on June 9 for "Method for treating acute ischemic stroke" (Chinese, Taiwanese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,942, issued on June 9, was assigned to LUMOSA THERAPEUTICS Co. LTD. (Taipei, Taiwan). "Method for treating acute ischemic stroke" was invent... Read More

US Patent Issued to Corcept Therapeutics on June 9 for "Treatment of adrenocortical carcinoma with selective glucocorticoid receptor modulators (SGRMs) and antibody checkpoint inhibitors" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,943, issued on June 9, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.). "Treatment of adrenocortical carcinoma with selecti... Read More

US Patent Issued to AB SCIENCE on June 9 for "Masitinib for the treatment of castrate-resistant prostate cancer" (French Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,944, issued on June 9, was assigned to AB SCIENCE (Paris). "Masitinib for the treatment of castrate-resistant prostate cancer" was invented ... Read More

US Patent Issued to ASCENTAGE PHARMA (SUZHOU), ASCENTAGE PHARMA GROUP on June 9 for "Compositions and methods for treating systemic lupus erythematosus" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,945, issued on June 9, was assigned to ASCENTAGE PHARMA (SUZHOU) Co. LTD. (Suzhou, China) and ASCENTAGE PHARMA GROUP CORP Ltd. (Hong Kong). ... Read More

US Patent Issued to DAIICHI SANKYO on June 9 for "Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,946, issued on June 9, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo). "Combination of antibody-pyrrolobenzodiazepine derivative conjug... Read More

US Patent Issued to Tolremo Therapeutics on June 9 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment, amelioration or prevention of fibrotic disease" (Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,947, issued on June 9, was assigned to Tolremo Therapeutics AG (Muttenz, Switzerland). "Heterocyclic derivatives, pharmaceutical composition... Read More

US Patent Issued to United States Government as represented by the Department of Veterans Affairs on June 9 for "Methods and compositions for treating cancer" (Texas Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,948, issued on June 9, was assigned to United States Government as represented by the Department of Veterans Affairs (Washington). "Methods ... Read More

US Patent Issued to Liqmeds Worldwide on June 9 for "Oral liquid formulation of rivaroxaban" (Indian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,950, issued on June 9, was assigned to Liqmeds Worldwide Ltd. (Weedon, Great Britain). "Oral liquid formulation of rivaroxaban" was invented... Read More

US Patent Issued to University of Chicago on June 9 for "Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists, androgen deprivation therapy and anti-androgen receptor therapy" (Illinois Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,951, issued on June 9, was assigned to University of Chicago (Chicago). "Methods of treating castration-resistant prostate cancer with gluco... Read More

• ««
• «
• 57667
• 57668
• 57669
• 57670
• 57671
• 57672
• 57673
• 57674
• 57675
• 57676
• »
• »»